The Development
The applied behavior analysis (ABA) therapy sector is navigating significant shifts, primarily driven by a dramatic increase in autism spectrum disorder (ASD) diagnoses and subsequent financial pressures on healthcare payers. Currently, 1 in 31 children are diagnosed with autism, a notable rise from 1 in 45 just a decade ago. This surge has led to unprecedented demand for ABA services, widely recognized as crucial for autism care. In response to escalating demands and financial strain, both state Medicaid agencies and commercial insurers are implementing strategies to curb spending. These include outright rate reductions, increased expectations for providers to demonstrate clear value and measurable outcomes, and a growing push for integrating non-ABA therapies into comprehensive autism care plans.
Jim Spink, CEO of Autism Care Partners, highlighted the challenging environment: “We’ve seen state Medicaid authorities reduce their rates, and then commercial payers try to follow suit, despite the increasing pressure on access. So for the provider, it’s really difficult.” This sentiment reflects widespread concern among providers. Several states have initiated or proposed significant cuts to ABA funding. Colorado and North Carolina, for instance, have faced legal challenges from providers and patient advocates after proposing reductions.
Indiana is poised for substantial shifts, having unveiled a plan in January to cap ABA service coverage and introduce new workforce regulations. More recently, a state working group proposed 20 recommendations, including lifetime caps on ABA hours, a mandate to align ABA utilization with clinical evidence, and a temporary moratorium on new ABA therapy sites. Similarly, Nebraska, once known for some of the nation’s highest ABA reimbursement rates, announced a drastic 48% cut in reimbursement for direct therapy provided by behavior technicians in July. Idaho’s Medicaid program also recently announced a significant structural change, moving “behavior modification and consultation,” including ABA, from its behavioral health managed care organization to the Children’s Habilitation Intervention Services (CHIS) program. This change means Magellan will no longer reimburse CPT codes related to ABA, creating uncertainty.
Beyond state Medicaid programs, large commercial payers are also scrutinizing ABA spending. Centene Corp. (NYSE: CNC) has repeatedly voiced concerns about ABA service expenditures during its earnings calls. In October, Centene established an ABA task force dedicated to addressing these costs, which has already collaborated with a state partner to enhance “precision in ABA clinical service definition” and implement “more stringent supervisory and caregiver engagement requirements.” These actions signal a broader industry trend towards greater accountability and cost control in ABA service delivery.
Market Impact
The confluence of rising demand and shrinking reimbursement rates is compelling ABA providers to fundamentally re-evaluate their operational and clinical strategies. The market is shifting towards a model where demonstrating value and measurable outcomes is paramount. Helen Mader, CEO of Behavior Frontiers, articulated this evolving dynamic, stating, “We work with many payers who are seeing that providing early intensive ABA services through the clinical outcomes that we provide to them … is actually the most cost-effective route for them, because these children can graduate from the therapy programs and then they no longer require lifelong services from that payer.” This perspective underscores the growing interest among payers in long-term efficacy and cost-effectiveness.
Payers are also increasingly investing in research to validate ABA’s efficacy. A significant development was a new report released in September by the National Academy of Sciences, commissioned by the U.S. Department of Defense’s Defense Health Agency. This report found ABA to be clinically effective, despite identifying policy complexities within the existing TRICARE demonstration program. This research could be a pivotal step towards ABA services becoming a fully covered benefit under TRICARE.
While value-based care arrangements remain relatively uncommon in the autism care sector, they are anticipated to gain traction as payers demand more concrete results. Cortica, an autism provider emphasizing a “whole-child approach,” exemplifies a model thriving in this emerging environment. Co-founder and CEO Neil Hattangadi explained, “The model just works better in a value-based care environment. Out of necessity and out of a vision for what the future of the field could look like, we embarked on this a few years ago.” Cortica’s strategy involves integrating various components of care to create value-based relationships, focusing on positive outcomes and reducing “unwanted spend.”
This focus on a “whole-child approach” also highlights another significant trend: the expansion of autism care beyond exclusive ABA services. Providers like Cortica offer a comprehensive suite of services, including medical care for common comorbidities such as seizures, sleep disorders, and gastrointestinal symptoms, alongside developmental therapies like speech and occupational therapy. This integrated model not only streamlines care coordination and reduces administrative burdens for families but also provides a crucial avenue for providers to diversify their revenue streams. The acquisition of Pediatric Advanced Therapy by JoyBridge Kids, which expanded its offerings to include speech, occupational, physical therapy, and counseling, further illustrates this strategic shift. Mike Cairnes, CEO of JoyBridge Kids, noted that Pediatric Advanced Therapy’s “reputation for clinical excellence and their focus on speech, occupational, physical therapy plus counseling perfectly complements our model of joyful, progressive ABA therapy.”
What’s Next
The evolving payer landscape necessitates that ABA providers adopt proactive strategies to ensure long-term sustainability and continued access to care. Scott Semmel, senior vice president of payer relations at Acorn Health, emphasized the critical need for providers to define their unique value proposition. “I really think we’re at a point where all providers need to figure out what their identity is when it comes to value proposition, what differentiates you from other providers in the space, but also to be forward thinking about more diverse service offerings and integrated approach to caring for these learners with autism care spectrum disorder,” Semmel advised. This involves not only demonstrating ABA’s clinical efficacy and cost-effectiveness but also exploring and integrating complementary services.
The trend towards diversification, particularly the incorporation of developmental therapies and medical care for comorbidities, is likely to accelerate. This approach not only enhances the quality and comprehensiveness of care for individuals with autism but also serves as a crucial “future-proofing” mechanism for organizations facing potential rate cuts and increased scrutiny from payers. Providers offering a broader spectrum of services will be better positioned to negotiate with payers, demonstrate holistic value, and adapt to changing reimbursement models. The potential for ABA services to achieve full coverage under TRICARE, spurred by recent research, also signals a broader recognition of ABA’s effectiveness, which could influence other payers. Ultimately, the future of ABA therapy will be characterized by a greater emphasis on integrated, outcome-driven care models that prioritize both clinical excellence and financial viability.
Fast Facts
| Key Point | Why It Matters for ABA |
|---|---|
| Autism diagnoses: 1 in 31 children | Highlights surging demand and pressure on payer systems. |
| Nebraska’s 48% cut for BT direct therapy | Illustrates the severity of state Medicaid rate reductions. |
| Indiana’s proposed lifetime caps and moratorium | Signals a trend towards stricter utilization management and site regulation. |
| Centene Corp. formed ABA task force | Indicates commercial payers’ increased scrutiny on ABA spending and clinical definitions. |
| National Academy of Sciences report found ABA clinically effective | Provides strong evidence for ABA’s efficacy, potentially influencing TRICARE and other payers. |
| Providers diversifying into integrated care (e.g., speech, OT, medical) | Crucial strategy for demonstrating holistic value and future-proofing revenue streams. |
Expert Perspective
Providers must clearly articulate their value proposition and embrace diversified, integrated service models to navigate evolving payer landscapes and ensure long-term sustainability.
Source: bhbusiness.com
